Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$344,236
+$97,738 QoQ
Shares Held
287
+7.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#4,061
of 4,605 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kilter Group LLC holds $1,385,854 across 15 Drug Manufacturers - General names. LLY ranks #2 (24.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
1,490 | $539,558 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
287 | $344,236 | |
| 3 | ABBV |
AbbVie Inc.
|
498 | $125,316 | |
| 4 | JNJ |
Johnson & Johnson
|
309 | $78,476 | |
| 5 | MRK |
Merck & Co., Inc.
|
480 | $61,680 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
360 | $45,482 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
605 | $34,860 | |
| 8 | NVS |
Novartis AG
|
209 | $32,754 |
All Filings in LLY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $344,236 | 287 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $246,498 | 268 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $386,884 | 360 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $66,381 | 87 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $65,480 | 84 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||